1-8 of 8
Martin W. Brechbiel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Yttrium-90 Radiolabeled Humanized Monoclonal Antibody to CD25 in Refractory and Relapsed Hodgkin’s Lymphoma

Deirdre O’Mahony, MD, John E Janik, MD, Jorge A. Carrasquillo, MD, Pamela Seam, MD, Joseph A Fiorillo, MD, Donn Stewart, MD, Chang H Paik, PhD, Suzanne Fioravanti, RN, Millie Whatley, RNMT, Stefania Pittaluga, MD, PhD, Martin W Brechbiel, PhD, John C Morris, MD, Thomas A Waldmann, MD
Journal: Blood
Blood (2008) 112 (11): 231.
https://doi.org/10.1182/blood.V112.11.231.231
Published: 2008
Journal Articles

Effective treatment of a murine model of adult T-cell leukemia using 211 At-7G7/B6 and its combination with unmodified anti-Tac (daclizumab) directed toward CD25

Zhuo Zhang, Meili Zhang, Kayhan Garmestani, Vladimir S. Talanov, Paul S. Plascjak, Barbara Beck, Carolyn Goldman, Martin W. Brechbiel, Thomas A. Waldmann
Journal: Blood
Blood (2006) 108 (3): 1007–1012.
https://doi.org/10.1182/blood-2005-11-4757
Published: 2006
Journal Articles

Effective therapy for a murine model of human anaplastic large-cell lymphoma with the anti-CD30 monoclonal antibody, HeFi-1, does not require activating Fc receptors

Meili Zhang, Zhengsheng Yao, Zhuo Zhang, Kayhan Garmestani, Carolyn K. Goldman, Jeffrey V. Ravetch, John Janik, Martin W. Brechbiel, Thomas A. Waldmann
Journal: Blood
Blood (2006) 108 (2): 705–710.
https://doi.org/10.1182/blood-2005-11-4607
Published: 2006
Journal Articles

Tachpyridine, a metal chelator, induces G 2 cell-cycle arrest, activates checkpoint kinases, and sensitizes cells to ionizing radiation

JoLyn Turner, Constantinos Koumenis, Timothy E. Kute, Roy P. Planalp, Martin W. Brechbiel, Dillon Beardsley, Brooke Cody, Kevin D. Brown, Frank M. Torti, Suzy V. Torti
Journal: Blood
Blood (2005) 106 (9): 3191–3199.
https://doi.org/10.1182/blood-2005-03-1263
Published: 2005
Journal Articles

Selective T-cell ablation with bismuth-213–labeled anti-TCRαβ as nonmyeloablative conditioning for allogeneic canine marrow transplantation

Wolfgang A. Bethge, D. Scott Wilbur, Rainer Storb, Donald K. Hamlin, Erlinda B. Santos, Martin W. Brechbiel, Darrell R. Fisher, Brenda M. Sandmaier
Journal: Blood
Blood (2003) 101 (12): 5068–5075.
https://doi.org/10.1182/blood-2002-12-3867
Published: 2003
Journal Articles

Targeted α particle immunotherapy for myeloid leukemia

Clinical Trials & Observations
Joseph G. Jurcic, Steven M. Larson, George Sgouros, Michael R. McDevitt, Ronald D. Finn, Chaitanya R. Divgi, Åse M. Ballangrud, Klaus A. Hamacher, Dangshe Ma, John L. Humm, Martin W. Brechbiel, Roger Molinet, David A. Scheinberg
Journal: Blood
Blood (2002) 100 (4): 1233–1239.
https://doi.org/10.1182/blood.V100.4.1233.h81602001233_1233_1239
Published: 2002
Journal Articles

Bismuth 213–labeled anti-CD45 radioimmunoconjugate to condition dogs for nonmyeloablative allogeneic marrow grafts

Brenda M. Sandmaier, Wolfgang A. Bethge, D. Scott Wilbur, Donald K. Hamlin, Erlinda B. Santos, Martin W. Brechbiel, Darrell R. Fisher, Rainer Storb
Journal: Blood
Blood (2002) 100 (1): 318–326.
https://doi.org/10.1182/blood-2001-12-0322
Published: 2002
Journal Articles

Pretargeting radioimmunotherapy of a murine model of adult T-cell leukemia with the α-emitting radionuclide, bismuth 213

Meili Zhang, Zhengsheng Yao, Kayhan Garmestani, Donald B. Axworthy, Zhuo Zhang, Robert W. Mallett, Louis J. Theodore, Carolyn K. Goldman, Martin W. Brechbiel, Jorge A. Carrasquillo, Thomas A. Waldmann
Journal: Blood
Blood (2002) 100 (1): 208–216.
https://doi.org/10.1182/blood-2002-01-0107
Published: 2002